[Evaluation of the hypotensive effect of captopril in patients with severe and treatment-resistant arterial hypertension]. 1988

S Grajek, and S Paradowski, and F Kozłowska, and M Gracz

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

S Grajek, and S Paradowski, and F Kozłowska, and M Gracz
July 1980, AMB : revista da Associacao Medica Brasileira,
S Grajek, and S Paradowski, and F Kozłowska, and M Gracz
May 1980, American heart journal,
S Grajek, and S Paradowski, and F Kozłowska, and M Gracz
May 1986, Lijecnicki vjesnik,
S Grajek, and S Paradowski, and F Kozłowska, and M Gracz
October 1986, Kardiologiia,
S Grajek, and S Paradowski, and F Kozłowska, and M Gracz
January 1987, Journal de gynecologie, obstetrique et biologie de la reproduction,
S Grajek, and S Paradowski, and F Kozłowska, and M Gracz
January 1987, Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR,
S Grajek, and S Paradowski, and F Kozłowska, and M Gracz
April 1982, The American journal of cardiology,
S Grajek, and S Paradowski, and F Kozłowska, and M Gracz
January 1988, Kardiologia polska,
S Grajek, and S Paradowski, and F Kozłowska, and M Gracz
January 1991, Urologiia i nefrologiia,
S Grajek, and S Paradowski, and F Kozłowska, and M Gracz
January 1985, Vojnosanitetski pregled,
Copied contents to your clipboard!